Follow the 보령 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 보령 has logged 45 reports. Market capitalisation: €686.8bn. The latest transaction was disclosed on 16 March 2026 (Other). Among the most active insiders: 보령파트너스. All data is openly available.
45
Insider Decl.
n/a
Thresholds
n/a
16 ops.
Buy Volume
n/a
1 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 4,797 of 28,169 companies
68.7
score / 100
Value
82
Quality
55
FCF yld15%
Earn yld9.4%
EV/EBITDA8.1x
ROE13%
Gross mgn37%
Net mgn6.3%
Debt/EBITDA2.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Boryung is a company in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the development and commercialization of pharmaceutical products.